| Bioactivity | Cbl-b-IN-26 (Example A1) is a Cbl-b inhibitor with a Kd of 34.6 nM. Cbl-b-IN-26 can be used in the study of chronic viral infections and cancer[1]. |
| CAS | 3035443-17-2 |
| Formula | C21H19F3N6 |
| Molar Mass | 412.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sujin Cho-Schultz, et al. Substituted 1 h-pyrazolo-pyridine and-pyrimidine compounds. WO, WO2024074977A1. 2024-04-11 |
Cbl-b-IN-26
CAS: 3035443-17-2 F: C21H19F3N6 W: 412.41
Cbl-b-IN-26 (Example A1) is a Cbl-b inhibitor with a Kd of 34.6 nM. Cbl-b-IN-26 can be used in the study of chronic vira
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.